Martin Worley Group »

Kalvista Pharmaceuticals shares owned by Martin Worley Group

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Martin Worley Group from 13F filings

Historical chart of Martin Worley Group investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Martin Worley Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Martin Worley Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $115k 10k 11.31
2025-03-31 $117k 10k 11.54
2024-12-31 $86k 10k 8.47

More positions owned by Martin Worley Group

Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Wellington Us Minimum (VFMV)
J P Morgan Exchange Traded F Municipal Etf (JMUB)
Vanguard Index Fds Growth Etf (VUG)
Pimco Etf Tr Inv Grd Crp Bd (CORP)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Internl Divid (SCHY)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
J P Morgan Exchange Traded F Income Etf (JPIE)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Dimensional Etf Trust Intl High Profit (DIHP)

View all positions for Martin Worley Group

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Frazier Life Sciences Management
Suvretta Capital Management
Capital World Investors
BlackRock
Vanguard Group
Millennium Management
Tudor Investment Corporation
Woodline Partners
Goldman Sachs Group
Parkman Healthcare Partners
Caption Management
State Street Corporation
Silverarc Capital Management

View all funds holding Kalvista Pharmaceuticals